放射性医薬品の世界市場2019-2027

◆英語タイトル:Radiopharmaceutical - Global Market Outlook (2019-2027)
◆商品コード:SMRC20JL382
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年6月30日
◆ページ数:185
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥435,750見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算¥551,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥787,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、放射性医薬品の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、ソース別(原子炉、サイクロトロン)分析、種類別分析、放射性同位体別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・放射性医薬品の世界市場規模:ソース別(原子炉、サイクロトロン)
・放射性医薬品の世界市場規模:種類別
・放射性医薬品の世界市場規模:放射性同位体別
・放射性医薬品の世界市場規模:用途別
・放射性医薬品の世界市場規模:エンドユーザー別
・放射性医薬品の世界市場規模:地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global Radiopharmaceutical Market is accounted for $3.76 billion in 2019 and is expected to reach $5.99 billion by 2027 growing at a CAGR of 6.0% during the forecast period. Some of the key factors propelling the market growth are technological advancements in the diagnostics sector, increasing prevalence of cancer, and increasing applications of molecular imaging. However, the short half-life of radioisotopes is the restraining factor for the growth of the market.

Pharmaceutical formulations that contain radioisotopes are known as radiopharmaceuticals. These are bound with the biological molecules and are targeted for the specific organs. The molecules resulting from these formulations find a wide range of applications in the therapeutic and diagnostic sectors.

By radioisotope, the Technetium-99 segment is expected to grow at a significant market share during the forecast period owing to its easy availability and extensive diagnostic applications. Based on geography, North America is anticipated to hold considerable market share during the forecast period owing to the presence of radioisotope sources in the region.

Some of the key players in Radiopharmaceutical Market include Lantheus Medical Imaging, Inc, GE Healthcare, Advanced Accelerator Applications, Mallinckrodt, Bayer AG, Siemens Healthineers, IBA Radiopharma Solutions, Eckert & Ziegler, Philips, Jubilant Life Sciences Limited, Novartis AG, BWX Technologies, Inc., POLATOM, JSC Isotope, NTP Radioisotopes SOC Ltd, Curium, Australian Nuclear Science and Technology Organization (ANSTO), Cardinal Health Inc., Covidien Plc, Positron Corporation, Monrol Nuclear Products,Inc, and Nordion, Inc.

Sources Covered:
• Nuclear Reactors
• Cyclotrons

Types Covered:
• Therapeutic
• Diagnostic

Radioisotopes Covered:
• Yttrium-90
• Thallium-201
• Technetium-99
• Strontium -89
• Samarium-153
• Rubidium-82
• Rhenium-186
• Radium-223
• Palladium – 103
• Leutetium-177
• Iridium – 192
• Iodine-131
• Iodine-125
• Iodine-123
• Indium-111
• Holmium-166
• Gallium-68
• Gallium-67
• Fluorine-18
• Fludeoxyglucose – (18F-FDG)
• Erbium-169
• Cesium-131
• Actinium-225

Applications Covered:
• Thyroid
• Theranostics
• Oncology
• Neurology
• Neuroendocrinology
• Nephrology
• Lymphoma
• Inflammation
• Gastroenterology
• Cardiology

End Users Covered:
• Ambulatory Surgical Centers
• Cancer Research Institute
• Diagnostic Imaging Centers
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Radiopharmaceutical Market, By Source
5.1 Introduction
5.2 Nuclear Reactors
5.3 Cyclotrons

6 Global Radiopharmaceutical Market, By Type
6.1 Introduction
6.2 Therapeutic
6.2.1 Alpha Emitters
6.2.2 Beta Emitters
6.2.3 Brachytherapy Isotopes
6.3 Diagnostic
6.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
6.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals

7 Global Radiopharmaceutical Market, By Radioisotope
7.1 Introduction
7.2 Yttrium-90
7.3 Thallium-201
7.4 Technetium-99
7.5 Strontium -89
7.6 Samarium-153
7.7 Rubidium-82
7.8 Rhenium-186
7.9 Radium-223
7.10 Palladium – 103
7.11 Leutetium-177
7.12 Iridium – 192
7.13 Iodine-131
7.14 Iodine-125
7.15 Iodine-123
7.16 Indium-111
7.17 Holmium-166
7.18 Gallium-68
7.19 Gallium-67
7.20 Fluorine-18
7.21 Fludeoxyglucose – (18F-FDG)
7.22 Erbium-169
7.23 Cesium-131

7.24 Actinium-225

8 Global Radiopharmaceutical Market, By Application
8.1 Introduction
8.2 Thyroid
8.3 Theranostics
8.4 Oncology
8.5 Neurology
8.6 Neuroendocrinology
8.7 Nephrology
8.8 Lymphoma
8.9 Inflammation
8.10 Gastroenterology
8.11 Cardiology

9 Global Radiopharmaceutical Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers
9.3 Cancer Research Institute
9.4 Diagnostic Imaging Centers
9.5 Hospitals

10 Global Radiopharmaceutical Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Lantheus Medical Imaging, Inc
12.2 GE Healthcare
12.3 Advanced Accelerator Applications
12.4 Mallinckrodt
12.5 Bayer AG
12.6 Siemens Healthineers
12.7 IBA Radiopharma Solutions
12.8 Eckert & Ziegler
12.9 Philips
12.10 Jubilant Life Sciences Limited
12.11 Novartis AG
12.12 BWX Technologies, Inc.
12.13 POLATOM
12.14 JSC Isotope
12.15 NTP Radioisotopes SOC Ltd
12.16 Curium
12.17 Australian Nuclear Science and Technology Organization (ANSTO)
12.18 Cardinal Health Inc.
12.19 Covidien Plc
12.20 Positron Corporation
12.21 Monrol Nuclear Products,Inc
12.22 Nordion,Inc.

List of Tables
Table 1 Global Radiopharmaceutical Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Radiopharmaceutical Market Outlook, By Source (2018-2027) ($MN)
Table 3 Global Radiopharmaceutical Market Outlook, By Nuclear Reactors (2018-2027) ($MN)
Table 4 Global Radiopharmaceutical Market Outlook, By Cyclotrons (2018-2027) ($MN)
Table 5 Global Radiopharmaceutical Market Outlook, By Type (2018-2027) ($MN)
Table 6 Global Radiopharmaceutical Market Outlook, By Therapeutic (2018-2027) ($MN)
Table 7 Global Radiopharmaceutical Market Outlook, By Alpha Emitters (2018-2027) ($MN)
Table 8 Global Radiopharmaceutical Market Outlook, By Beta Emitters (2018-2027) ($MN)
Table 9 Global Radiopharmaceutical Market Outlook, By Brachytherapy Isotopes (2018-2027) ($MN)
Table 10 Global Radiopharmaceutical Market Outlook, By Diagnostic (2018-2027) ($MN)
Table 11 Global Radiopharmaceutical Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2018-2027) ($MN)
Table 12 Global Radiopharmaceutical Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2018-2027) ($MN)
Table 13 Global Radiopharmaceutical Market Outlook, By Radioisotope (2018-2027) ($MN)
Table 14 Global Radiopharmaceutical Market Outlook, By Yttrium-90 (2018-2027) ($MN)
Table 15 Global Radiopharmaceutical Market Outlook, By Thallium-201 (2018-2027) ($MN)
Table 16 Global Radiopharmaceutical Market Outlook, By Technetium-99 (2018-2027) ($MN)
Table 17 Global Radiopharmaceutical Market Outlook, By Strontium -89 (2018-2027) ($MN)
Table 18 Global Radiopharmaceutical Market Outlook, By Samarium-153 (2018-2027) ($MN)
Table 19 Global Radiopharmaceutical Market Outlook, By Rubidium-82 (2018-2027) ($MN)
Table 20 Global Radiopharmaceutical Market Outlook, By Rhenium-186 (2018-2027) ($MN)
Table 21 Global Radiopharmaceutical Market Outlook, By Radium-223 (2018-2027) ($MN)
Table 22 Global Radiopharmaceutical Market Outlook, By Palladium – 103 (2018-2027) ($MN)
Table 23 Global Radiopharmaceutical Market Outlook, By Leutetium-177 (2018-2027) ($MN)
Table 24 Global Radiopharmaceutical Market Outlook, By Iridium – 192 (2018-2027) ($MN)
Table 25 Global Radiopharmaceutical Market Outlook, By Iodine-131 (2018-2027) ($MN)
Table 26 Global Radiopharmaceutical Market Outlook, By Iodine-125 (2018-2027) ($MN)
Table 27 Global Radiopharmaceutical Market Outlook, By Iodine-123 (2018-2027) ($MN)
Table 28 Global Radiopharmaceutical Market Outlook, By Indium-111 (2018-2027) ($MN)
Table 29 Global Radiopharmaceutical Market Outlook, By Holmium-166 (2018-2027) ($MN)
Table 30 Global Radiopharmaceutical Market Outlook, By Gallium-68 (2018-2027) ($MN)
Table 31 Global Radiopharmaceutical Market Outlook, By Gallium-67 (2018-2027) ($MN)
Table 32 Global Radiopharmaceutical Market Outlook, By Fluorine-18 (2018-2027) ($MN)
Table 33 Global Radiopharmaceutical Market Outlook, By Fludeoxyglucose – (18F-FDG) (2018-2027) ($MN)
Table 34 Global Radiopharmaceutical Market Outlook, By Erbium-169 (2018-2027) ($MN)
Table 35 Global Radiopharmaceutical Market Outlook, By Cesium-131 (2018-2027) ($MN)
Table 36 Global Radiopharmaceutical Market Outlook, By Actinium-225 (2018-2027) ($MN)
Table 37 Global Radiopharmaceutical Market Outlook, By Application (2018-2027) ($MN)
Table 38 Global Radiopharmaceutical Market Outlook, By Thyroid (2018-2027) ($MN)
Table 39 Global Radiopharmaceutical Market Outlook, By Theranostics (2018-2027) ($MN)
Table 40 Global Radiopharmaceutical Market Outlook, By Oncology (2018-2027) ($MN)
Table 41 Global Radiopharmaceutical Market Outlook, By Neurology (2018-2027) ($MN)
Table 42 Global Radiopharmaceutical Market Outlook, By Neuroendocrinology (2018-2027) ($MN)
Table 43 Global Radiopharmaceutical Market Outlook, By Nephrology (2018-2027) ($MN)
Table 44 Global Radiopharmaceutical Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 45 Global Radiopharmaceutical Market Outlook, By Inflammation (2018-2027) ($MN)
Table 46 Global Radiopharmaceutical Market Outlook, By Gastroenterology (2018-2027) ($MN)
Table 47 Global Radiopharmaceutical Market Outlook, By Cardiology (2018-2027) ($MN)
Table 48 Global Radiopharmaceutical Market Outlook, By End User (2018-2027) ($MN)
Table 49 Global Radiopharmaceutical Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 50 Global Radiopharmaceutical Market Outlook, By Cancer Research Institute (2018-2027) ($MN)
Table 51 Global Radiopharmaceutical Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 52 Global Radiopharmaceutical Market Outlook, By Hospitals (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[放射性医薬品の世界市場2019-2027]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆